The World Leader In Molecular Breast Imaging To Premiere Largest Detector In The Industry
6/03/2011
Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM) Meeting in San Antonio, Texas, with the premiere of its FDA-cleared Dilon 6800® Acella Gamma Camera system...
National Clinical Trial To Test Novel Approach To Treat Triple-Negative Breast Cancer
6/03/2011
A multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women...
Morphotek®, Inc. Announces Initiation Of MORAb-004 Phase II Study In Melanoma
6/03/2011
Morphotek®, Inc., a subsidiary of Eisai Inc., announced that it has commenced a multi-center, phase II study of MORAb-004 for the treatment of metastatic melanoma...
Taking Advantage Of The High Iron Requirements Of Brain Cancer Cells To Improve Treatment
6/03/2011
Brain cancer therapy may be more effective if the expression of an iron-storing protein is decreased to enhance the action of therapeutic drugs on brain cancer cells, according to Penn State College of Medicine researchers. Malignant glioblastoma multiforme is a deadly brain tumor for which no long-term effective cure exists...
FSU Scientist Leads Research On AIDS-Related Cancer
6/03/2011
In the early days of the AIDS epidemic, a once-rare form of cancer known as Kaposi's sarcoma (KS) emerged as a frequent harbinger of HIV. Its stigma was best illustrated by Tom Hanks, who portrayed a gay man trying to conceal the cancerous skin lesions from his co-workers in the 1993 movie "Philadelphia...
Use Of Clot Busters For Stroke Increased From 2005 To 2009, But Still Low
6/03/2011
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 - but is still low, according to research reported in Stroke: Journal of the American Heart Association...
C-reactive Protein Levels Predict Breast Cancer Survival Rates
6/02/2011
Levels of C-reactive protein (CRP) are increased in response to acute inflammation, infection and tissue damage. There are also reports that CRP levels are elevated because of cancer. New research published in BioMed Central's open access journal Breast Cancer Research shows that elevated CRP levels are predictive of a poor prognosis for breast cancer sufferers...
Giants Roche, Bristol Team Up To Combat Deadly Melanoma With Combo
6/02/2011
There are several ways to combat deadly melanoma. One way is to attack the cancer by bolstering the body's immune system to fight the disease. Another way is to block a genetic mutation known as BRAF, which may help the disease grow. This week it was announced that two giants, Bristol Meyers Squibb and Roche will combine forces to find a best practice solution...
Antifungal Drug Delays Need For Chemo In Advanced Prostate Cancer
6/02/2011
The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease...
Understanding Cancer Energetics
6/02/2011
It's long been known that cancer cells eat a lot of sugar to stay alive. In fact, where normal, noncancerous cells generate energy from using some sugar and a lot of oxygen, cancerous cells use virtually no oxygen and a lot of sugar...